Media & Press releases

Media

BIOTECH FINANCES

February 21, 2022

Nervosave défie la CMT1A

Nature Communications

April 21, 2021

AAV2/9-mediated silencing of PMP22 prevents the development of pathological features in a rat model of Charcot-Marie-Tooth disease 1 A

INSERM

April 21, 2021

La thérapie génique, un espoir contre les maladies de Charcot‑Marie‑Tooth

INSERM

August 17, 2017

ERC Laureates 2012

AFNP

La myéline du nerf périphérique

Myology 2019

April 2, 2019

Nicolas Tricaud et les maladies de Charcot-Marie-Tooth

Press releases

October 21, 2021

Foundation of Nervosave Therapeutics!